Hyperprolactinemia in polycystic ovary syndrome

Area of Science:

• Endocrinology
• Reproductive Medicine
• Neuroendocrinology

Background:

• Polycystic ovary syndrome (PCOS) is a common endocrine disorder.
• Hyperprolactinemia is observed in a subset of PCOS patients.
• The underlying pathophysiology of PCOS is not fully understood.

Purpose of the Study:

• To investigate the prevalence of hyperprolactinemia in PCOS patients.
• To compare pituitary and adrenal function in normoprolactinemic and hyperprolactinemic PCOS patients.
• To explore the potential role of hypothalamic dopaminergic activity in PCOS pathogenesis.

Main Methods:

• Prevalence study involving 150 PCOS patients.
• Hormonal evaluation including prolactin, thyrotropin, testosterone, luteinizing hormone (LH), and follicle-stimulating hormone (FSH).
• Pituitary and adrenal function tests (GnRH, TRH, dexamethasone suppression, ACTH stimulation) in subgroups of PCOS patients.

Main Results:

• Hyperprolactinemia was found in 17% of PCOS patients.
• Pituitary and adrenal perturbation tests were normal in both normoprolactinemic and hyperprolactinemic PCOS groups.
• Hyperprolactinemic PCOS patients exhibited higher prolactin, thyrotropin, testosterone, and LH/FSH ratio, with lower FSH levels and FSH response to GnRH.

Conclusions:

• The findings support a hypothesis of central dopaminergic deficiency in the hypothalamus contributing to PCOS pathogenesis.
• Hyperprolactinemia in PCOS may signify a more pronounced hypothalamic dopamine deficiency.
• Elevated basal prolactin and thyrotropin levels in hyperprolactinemic PCOS patients reflect this deficiency.